zalcitabine has been researched along with neopterin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boucher, CA; Hill, A; Ingrand, D; Katlama, C; Kitchen, V; McBride, M; McDade, H; Tubiana, R; van Leeuwen, R; Weber, J | 1 |
Aziz, N; Cumberland, WG; Fahey, JL; Liu, M; Merigan, T; Skowron, G | 1 |
Bartlett, JA; Benoit, SL; Ehmann, WC; Fallon, MA; Johnson, VA; Quinn, JB; Rubin, M; Self, PL; Sepulveda, GE; Tsoukas, C | 1 |
al-Attar, I; Burchett, SK; Chatis, P; Fuchs, D; Kornegay, J; McIntosh, K; Orav, J; Wachter, H; Zaknun, D; Zaknun, J | 1 |
3 trial(s) available for zalcitabine and neopterin
Article | Year |
---|---|
Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study.
Topics: Adult; Antiviral Agents; beta 2-Microglobulin; Biomarkers; Biopterins; CD4 Lymphocyte Count; Disease Progression; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Neopterin; Zalcitabine | 1995 |
Zidovudine and dideoxycytidine differ in their effects on human immunodeficiency virus-induced pathologic activation of the immune system. AIDS Clinical Trial Research Group 047.
Topics: Acquired Immunodeficiency Syndrome; beta 2-Microglobulin; Biopterins; HIV Core Protein p24; Humans; Immune System; Neopterin; Zalcitabine; Zidovudine | 1994 |
Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
Topics: Adult; Antiviral Agents; beta 2-Microglobulin; Biopterins; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Core Protein p24; HIV Infections; Humans; Lamivudine; Male; Neopterin; Polymerase Chain Reaction; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Zalcitabine; Zidovudine | 1996 |
1 other study(ies) available for zalcitabine and neopterin
Article | Year |
---|---|
Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease. A retrospective, longitudinal study of vertically acquired human immunodeficiency virus type 1 infection in children.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biopterins; CD4 Lymphocyte Count; Child; Child, Preschool; Female; HIV Core Protein p24; HIV-1; Humans; Infant; Longitudinal Studies; Male; Neopterin; Polymerase Chain Reaction; Retrospective Studies; RNA, Viral; Viral Load; Zalcitabine; Zidovudine | 1997 |